Ningbo Severe Mental Disorders Cohort (NEED)

April 17, 2024 updated by: Liya Liu, Ningbo University

Ningbo Severe Mental Disorders Cohort, a Longitudinal Population-based Ambispective Cohort Study

In recent years, the prevalence of severe mental disorders in China has continued to grow, and the burden of disease in society has continued to rise. In order to improve the prognosis of patients with severe mental disorders and reduce the risk of disease relapse or readmission, researchers established a cohort based on the Ningbo Mental Health Information System in Ningbo, a sub-provincial city in the southern wing of the Yangtze River Delta of China, with a resident population of more than 9 million, and linked it to the residents' health records, and through the data linkage obtained data on patients in the full cycle of pre-diagnosis, diagnosis, follow-up, disease changes and death, realising full-cycle management of patients with severe mental disorders.

Currently, NEED has accumulated data on more than 50,000 patients with severe mental disorders and obtained multi-dimensional longitudinal information through long-term follow-up and data linkage. All diseases follow the World Health Organization International Classification of Diseases 10th Edition (ICD-10) for clinical coding, and available data include baseline demographics, past history, family history, social functioning deficit screening scale scores, risk assessment, and so on and longitudinal health information from electronic health records (EHR), providing a solid data base for future real-world studies.

Study Overview

Study Type

Observational

Enrollment (Actual)

57212

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Zhejiang
      • Ningbo, Zhejiang, China, 315000
        • Ningbo Mental Health Information System

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients with severe mental disorder registered in the Ningbo Mental Health Information Management System

Description

Inclusion Criteria:

  • Clinical diagnosis of schizophrenia (F20)
  • Clinical diagnosis of schizo-affective disorder (F25)
  • Clinical diagnosis of paranoid psychoses (F22)
  • Clinical diagnosis of bipolar disorder (F30-F31)
  • Clinical diagnosis of epileptic psychosis (F06.8)
  • Clinical diagnosis of mental retardation (F70-F79)

Exclusion Criteria:

  • None.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients with severe mental disorders
Patients with severe mental disorders identified based on exposures of interest to the study

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Risk of circulatory system diseases
Time Frame: At least 1 year after being diagnosed with severe mental disorders during the study period (2019-2023)

At least one of the following diagnoses in the electronic health records : Primary hypertension (I10), Cerebral infarction (I63), Transient cerebral ischaemic attacks and related syndromes (G45), Intracerebral haemorrhage (I61), Subarachnoid haemorrhage (I60), Hemorrhagic stroke (I60-I61), Stroke (I60-I64, I69), Pulmonary embolism (I26), Aortic aneurysm and dissection (I71), Cardiovascular disease (I20-I25), Atrial fibrillation (I48), Cardiomyopathy (I42), Peripheral vascular diseases (I73), Myocardial infarction (I21-I22), Heart failure (I50).

Calculation of Hazard ratios(HRs) with 95% confidence intervals, comparing the risk of illness in persons with severe mental disorders with those without severe mental disorders.

At least 1 year after being diagnosed with severe mental disorders during the study period (2019-2023)
Risk of endocrine system diseases
Time Frame: At least 1 year after being diagnosed with severe mental disorders during the study period (2019-2023)

At least one of the following diagnoses in the electronic health records : Diabetes mellitus (E10-E14), Thyroid disorder (E00-E05, E61-E69, E07), Gout (E79, M10).

Calculation of Hazard ratios(HRs) with 95% confidence intervals, comparing the risk of illness in persons with severe mental disorders with those without severe mental disorders.

At least 1 year after being diagnosed with severe mental disorders during the study period (2019-2023)
Risk of pulmonary system and allergy diseases
Time Frame: At least 1 year after being diagnosed with severe mental disorders during the study period (2019-2023)

At least one of the following diagnoses in the electronic health records : Chronic pulmonary disease (J40-J47), Allergy (J30.1-J30.4, L23, L50.0, T78.0, T78.2, T78.4).

Calculation of Hazard ratios(HRs) with 95% confidence intervals, comparing the risk of illness in persons with severe mental disorders with those without severe mental disorders.

At least 1 year after being diagnosed with severe mental disorders during the study period (2019-2023)
Risk of gastrointestinal system diseases
Time Frame: At least 1 year after being diagnosed with severe mental disorders during the study period (2019-2023)

At least one of the following diagnoses in the electronic health records : Ulcer/chronic gastritis (K22.1, K25-K28, K29.3-K29.5), Chronic liver disease (B16-B19, K70, K74, K76.6, I85), Inflammatory bowel disease (K50-K51), Diverticular disease of intestine (K57).

Calculation of Hazard ratios(HRs) with 95% confidence intervals, comparing the risk of illness in persons with severe mental disorders with those without severe mental disorders.

At least 1 year after being diagnosed with severe mental disorders during the study period (2019-2023)
Risk of musculoskeletal system diseases
Time Frame: At least 1 year after being diagnosed with severe mental disorders during the study period (2019-2023)

At least one of the following diagnoses in the electronic health records :Connective tissue disorders (M05-M06, M08-M09, M30-M36, D86), Osteoporosis (M80-M82).

Calculation of Hazard ratios(HRs) with 95% confidence intervals, comparing the risk of illness in persons with severe mental disorders with those without severe mental disorders.

At least 1 year after being diagnosed with severe mental disorders during the study period (2019-2023)
Risk of urogenital system diseases
Time Frame: At least 1 year after being diagnosed with severe mental disorders during the study period (2019-2023)

At least one of the following diagnoses in the electronic health records : Chronic kidney disease (N03, N11, N18-N19), Prostate disorders (N40).

Calculation of Hazard ratios(HRs) with 95% confidence intervals, comparing the risk of illness in persons with severe mental disorders with those without severe mental disorders.

At least 1 year after being diagnosed with severe mental disorders during the study period (2019-2023)
Risk of hematological system diseases
Time Frame: At least 1 year after being diagnosed with severe mental disorders during the study period (2019-2023)

At least one of the following diagnoses in the electronic health records : HIV/AIDS (B20-B24), Anemias (D50-D53, D55-D59, D60-D61, D63-D64).

Calculation of Hazard ratios(HRs) with 95% confidence intervals, comparing the risk of illness in persons with severe mental disorders with those without severe mental disorders.

At least 1 year after being diagnosed with severe mental disorders during the study period (2019-2023)
Risk of cancers
Time Frame: At least 1 year after being diagnosed with severe mental disorders during the study period (2019-2023)
Diagnosed with cancer (C00-C43, C45-C97) in electronic health records. Calculation of Hazard ratios(HRs) with 95% confidence intervals, comparing the risk of illness in persons with severe mental disorders with those without severe mental disorders.
At least 1 year after being diagnosed with severe mental disorders during the study period (2019-2023)
Risk of neurological system diseases
Time Frame: At least 1 year after being diagnosed with severe mental disorders during the study period (2019-2023)

At least one of the following diagnoses in the electronic health records :Vision problem (H40, H25, H54), Hearing problem (H90-H91, H93.1), Migraine (G43), Epilepsy (G40-G41), Parkinson's disease (G20-G22), Multiple sclerosis (G35), Neuropathies (G50-G64).

Calculation of Hazard ratios(HRs) with 95% confidence intervals, comparing the risk of illness in persons with severe mental disorders with those without severe mental disorders.

At least 1 year after being diagnosed with severe mental disorders during the study period (2019-2023)
Risk of suicide
Time Frame: Recorded during the study period (2019-2023)

At least one of the following records in the Ningbo Mental Health Information System: attempted suicide, suicide, death by suicide.

Calculation of Hazard ratios(HRs) with 95% confidence intervals, comparing the risk of illness in persons with severe mental disorders with those without severe mental disorders.

Recorded during the study period (2019-2023)
Risk of violence
Time Frame: Recorded during the study period (2019-2023)

At least one of the following records in the Ningbo Mental Health Information System: causing trouble, causing an accident, committing an offence, injuring another person.

Calculation of Hazard ratios(HRs) with 95% confidence intervals, comparing the risk of illness in persons with severe mental disorders with those without severe mental disorders.

Recorded during the study period (2019-2023)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2018

Primary Completion (Actual)

December 31, 2023

Study Completion (Estimated)

December 31, 2026

Study Registration Dates

First Submitted

April 12, 2024

First Submitted That Met QC Criteria

April 12, 2024

First Posted (Actual)

April 17, 2024

Study Record Updates

Last Update Posted (Actual)

April 18, 2024

Last Update Submitted That Met QC Criteria

April 17, 2024

Last Verified

April 1, 2024

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Schizophrenia

Clinical Trials on Patient with severe mental disorder without intervention

3
Subscribe